Nephroscan Injection, Powder, Lyophilized, For Solution
FDA Label NDC 71083-0020

24 label sections · Submitted to the FDA by Theragnostics Inc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Theragnostics Inc for the product Nephroscan (NDC 71083-0020). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 radiation safety – drug handling, 2.2 patient preparation, 2.4 drug preparation, 2.5 radiochemical purity determination, 2.6 administration, 2.7 image acquisition, 2.8 radiation dosimetry, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.